1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

China Animal Vaccine Industry Report, 2016-2020

  • June 2016
  • 156 pages
  • Research In China
Report ID: 78007

Summary

Table of Contents

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen slower growth due to quality safety, high maturity and other factors, while the animal vaccine markets in emerging countries including China have developed rapidly.

The Chinese animal vaccine market size grew from RMB1.4 billion in 2004 to RMB14.0 billion in 2014 at a high rate of 25.9%, and is expected to hit around RMB16.9 billion in 2015, a year-on-year increase of 20.7%.

In China, animal vaccines fall into two categories: 1. Epidemic disease vaccines subject to national compulsory immunization programme (compulsory immunization vaccines include highly pathogenic avian influenza vaccine, foot-and-mouth disease vaccine, highly pathogenic PRRS vaccine, swine fever vaccine, and PPR vaccine in Xinjiang and Tibet); 2. Epidemic disease vaccines beyond national compulsory immunization programme (non-compulsory immunization vaccines). As the problems like low price and low quality caused by the system of purchasing by invitation to bid have greatly impacted the development of livestock and poultry breeding in China, the government has been piloting reform of the tendering system in multiple regions, planning to advance the marketization of vaccines through direct subsidies to farmers.

Large breeding companies, out of overall consideration based on economic benefits, are increasingly inclined to buy high-quality market-oriented vaccines which are 5-15 times as expensive as vaccines purchased under policy. Hence, the Chinese animal vaccine market size is expected to grow significantly in the future, reaching RMB41.2 billion in 2020.

Despite a large number of animal vaccine companies (about 100) in China, the industry is less concentrated. In 2015, China Animal Husbandry Industry Co., Ltd. (CAHIC) held the largest share (7.4%) of the Chinese animal vaccine market in 2015, followed by Jinyu Bio-technology (7.2%), Qingdao Yebio Biological Engineering (5.0%), Xinjiang Tecon Animal Husbandry Bio-Technology (4.6%), Pulike Biological Engineering (2.8%), and Tianjin Ringpu Bio-technology (2.8%).

Although the Chinese animal vaccine market is primarily controlled by domestic companies with a share of 90% or so, the high-end vaccine market, such as pet vaccines, is occupied by foreign brands including Zoetis (formerly Pfizer’s animal health division), Fort Dodge, Intervet, Merial, and BoehringerIngelheim. These foreign players not only directly sell vaccines in China but also have been increasing their investment in the country.

In 2014, the animal vaccine manufacturing base, with total investment of EUR55.5 million and jointly founded by BoehringerIngelheim and Taizhou China Medical City, started construction. Some pig vaccines will be first commercialized in the China Medical City after the manufacturing base is completed in 2016. Intervet Holding BV and CAHIC signed a cooperation agreement in 2015, planning to jointly explore domestic and foreign markets and enhance competitiveness.

However, Chinese local animal vaccine companies are also scaling up efforts for research and development, making their presence in high-end vaccines and expanding varieties of vaccines. There were 25 kinds of registered animal vaccines in China in 2015, a year-on-year growth of 78.6%, including 10 kinds of pig vaccines, 10 kinds of poultry vaccines, and 5 kinds of other animal vaccines like Mink Hemorrhagic Pneumonia Bivalent Vaccine, Inactivated (Serotype G, Stain WD005 + Serotype B, Stain DL007) and Turbot EdwardsiellatardaVaccine, Live (Strain EIBAV1).

Moreover, great progress has been made in pet vaccines. Rabies vaccines, inactivated produced by Pulike Biological Engineering, Tianjin Ringpu Bio-technology, and Shanghai Hile Bio-Technology are expected to be approved and go on the market at the end of 2016 or in 2017.

China Animal Vaccine Industry Report, 2016-2020 by ResearchInChina highlights the followings:
Global animal vaccine industry (market size/structure, competitive landscape, etc.);
China’s animal vaccine industry (market size/structure, competitive landscape, import/export, etc.);
China’s animal vaccine industry (policy environment, social environment, downstream demand, etc.);
Market segments (pig vaccines, poultry vaccines) in China (market size, competitive landscape, etc.);
16 Chinese animal vaccine producers (operation, animal vaccine business, forecast & outlook, etc.);
Chinese animal vaccine market and market segments (market size/structure forecast) during 2016-2020.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Vaccine Markets in the World to 2021 - Market Size, Development, and Forecasts

  • $ 23395
  • Industry report
  • July 2017
  • by Global Research & Data Services

The expansion of the global vaccine industry is forecast to reach 1.5% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 8.6%. Currently, human vaccines ...

Vaccine Markets in Europe to 2021 - Market Size, Development, and Forecasts

  • $ 12090
  • Industry report
  • July 2017
  • by Global Research & Data Services

The industry report package Vaccine Markets in Europe to 2021 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for vaccines ...

Vaccine Markets in Asia to 2021 - Market Size, Development, and Forecasts

  • $ 9031
  • Industry report
  • July 2017
  • by Global Research & Data Services

The industry report package Vaccine Markets in Asia to 2021 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for vaccines ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.